SEC Filing Analysis: HERON THERAPEUTICS, INC. /DE/ (HRTX)

Executive Summary

• Trading Significance: Low
• Key Takeaway: CEO Craig A. Collard acquired 34,789 shares of common stock upon the vesting of Restricted Stock Units (RSUs), a routine, non-market transaction related to his compensation.
• Market Impact: The transaction has a negligible market impact as it is not an open-market trade and represents a very small percentage of the company's outstanding shares.

Company Information

Field	Value
Company	HERON THERAPEUTICS, INC. /DE/
Ticker Symbol	HRTX
CIK	0000818033
Industry	PHARMACEUTICAL PREPARATIONS [2834]

Insider Information

Field	Value
Name	Collard Craig A
CIK	0001363558
Title/Position	Chief Executive Officer
Relationship	Director, Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-31
Transaction Code	M - Exercise or conversion of derivative security
Security Type	Common Stock
Shares Involved	34,789
Price Per Share	$0.00
Total Value	$0
Shares Owned After	523,124
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0 (Vesting event)
% of Market Cap	0.00%
Shares Transacted	34,789
% of Shares Outstanding	0.019%
Post-Transaction Ownership	523,124 shares (0.285% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a $210 million market capitalization, this transaction is immaterial. It is a standard compensation event, not a capital allocation decision by the insider.
• Ownership Concentration: The CEO's post-transaction ownership of 0.285% is a minor stake and does not significantly alter the company's ownership structure.
• Dilution Impact: The vesting of 34,789 shares results in a minimal dilution of 0.019% to existing shareholders, which is a routine and expected occurrence for companies with equity compensation plans.
• Transaction Significance: The transaction is rated as low significance because it is a non-discretionary vesting of RSUs, not an open-market trade. It does not signal any new insider sentiment regarding the company's valuation or prospects. The size is negligible relative to both market cap and total shares outstanding.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a non-market transaction (RSU vesting) that was part of a pre-arranged compensation plan. It provides no new information about the insider's current view of the company's valuation.

Volume & Sentiment

• Expected Volume Impact: None. The transaction is an issuance of equity and does not impact public trading volumes.
• Sentiment Indicator: Neutral. The event is a routine part of executive compensation and does not carry a bullish or bearish signal.

Additional Context

Transaction Notes

• The transaction, coded 'M', represents the vesting of Restricted Stock Units and the corresponding acquisition of common stock at a $0 cost basis. This is a standard executive compensation event, as confirmed by the footnotes in the filing.